Elekta signs agreement with US Oncology

6 September 2006

Stockholm, Sweden. Elekta has signed a three-year agreement with US Oncology outlining pricing and terms and conditions for supplying intensity modulated and image guided radiation therapy to the healthcare service network members.

US Oncology is the USA's largest healthcare services network devoted exclusively to cancer treatment and research, and a pioneer in community-based cancer care since 1993. The network has over 850 affiliated physicians at 460 sites of services, including 85 cancer centres, in 32 states. US Oncology delivers care to more than half a million cancer patients each year — including over 15% of all newly diagnosed U.S. cases.

This agreement opens up the possibility for members of US Oncology to acquire advanced digital linear accelerators from Elekta, capable of intensity modulated radiation therapy (IMRT) and 3D X-ray Volume Imaging for image-guided radiation therapy (IGRT), developed for addressing the problems of organ movement and patient set-up uncertainties in radiation therapy.

Through this agreement, US Oncology regional members can now include Elekta as a vendor for consideration. The agreement parallels a current agreement between US Oncology and IMPAC Medical Systems, an Elekta company, covering software systems for improved efficiency across the spectrum of cancer care.

"We are proud to be associated with US Oncology and are looking forward for this new opportunity to provide the network members with the most advanced clinical solutions for IMRT and IGRT", said  Anthony De Carolis, CEO of Elekta, Inc. and President of Elekta operations in North America.

To top

To top